Clinical Trial Update: Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating efficacy and safety of SCM-CGH in patients with chronic graft-versus-host disease that is steroid-refractory or dependent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• SCM-CGH (SCM-CGH)

Snippet

Sponsor: SCM Lifescience Co., LTD. | Conditions: Chronic Graft-versus-host-disease | Phase 2 | Status: UNKNOWN